Fresh Tracks Therapeutics Inc. (FRTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fresh Tracks Therapeutics...

    NASDAQ: FRTX · Real-Time Price · USD
    0.94
    0.00 (0.00%)
    At close: Feb 28, 2025, 12:19 PM

    Fresh Tracks Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -5.69M -21.1M -39.47M
    Depreciation & Amortization
    		 41K 30K 22K
    Stock-Based Compensation
    		 1.92M 2.16M 2.26M
    Other Working Capital
    		 -504K 556K -1.58M
    Other Non-Cash Items
    		 60K -132.01M 2.03M
    Deferred Income Tax
    		 n/a 132.07M -437K
    Change in Working Capital
    		 -669K -478K -556K
    Operating Cash Flow
    		 -4.34M -19.34M -36.15M
    Capital Expenditures
    		 n/a -47K -36K
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 n/a -47K -36K
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -38K -18K 8.95M
    Financial Cash Flow
    		 6.53M 1.18M 32.95M
    Net Cash Flow
    		 2.19M -18.2M -3.23M
    Free Cash Flow
    		 -4.34M -19.38M -36.18M

    Add to Watchlist